The 10th annual Amsterdam Immunogenicity and Tolerance Seminar will take place on Friday, November 8th, 2024 from 9:30am – 7:30 pm. All events (including a networking session with beer, wine and snacks!) will be located at the Hilton Apollolaan in Amsterdam.

Please note: this is an in-person event with no option for virtual attendance.

About the Amsterdam Immunogenicity & Tolerance Seminar:
Now in its 10th year, the Amsterdam Immunogenicity & Tolerance Seminar has become a much-anticipated forum for sharing research and ideas in the fields of immunogenicity and tolerance.  Academic and industry research has progressed significantly in the past several years. Traditional protein therapeutics research has expanded in complexity to include Bispecific and Multispecifc antibodies, fusion proteins, and peptide therapeutics. All these exciting developments have generated many questions and added complexity for immunologists, drug developers and medical practitioners working to deliver safe and effective therapies.


Check out past year’s AIT Seminars:

2023 Amsterdam Immunogenicity & Tolerance Seminar

2022 Amsterdam Immunogenicity & Tolerance Seminar

2021 Amsterdam Immunogenicity & Tolerance Seminar


Are you interested in speaking or presenting a poster at the conference? Submit a one page abstract here

A special thanks to the AIT23 Organizing Committee:

Corine Kruiswijk (Director, Translational Research, Intravacc), Christiane Gerke, PhD (Head of Vaccine Programs & Vaccine Innovation Development, Institut Pasteur), Marcel Hoefnagel (Senior Scientist/Assessor, College ter Beoordeling van Geneesmiddelen), Elly van Riet (Senior Scientist, TuBerculosis Vaccine Initiative), Annie De Groot, MD (CEO/CSO, EpiVax Inc.) and Brian Roberts, PhD (Scientific Director, Preclinical Immunology, EpiVax Inc.),

Questions or suggestions? Contact EpiVax: